First, we assessed primary colon cancers for the expression of nuclear β-catenin and FRA1 as surrogate markers for high WNT and MAPK signaling15, 16 that were previously linked to tumor-initiating potential and colon cancer stem cells. This evidence concerns the gene FOSL1 and neoplasm.